# In Vitro NSCLC EGFR-Mutant Models for Drug Sensitivity Testing

> **NCT07697716** · — · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 30 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- EGFR Gene Mutation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07697716
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697716, "In Vitro NSCLC EGFR-Mutant Models for Drug Sensitivity Testing". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*